Sarcopenia as a prognostic indicator of liver cirrhosis.
作者信息
Kim Sung-Eun, Kim Dong Joon
机构信息
Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea.
Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea.
出版信息
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):8-10. doi: 10.1002/jcsm.12869. Epub 2021 Nov 23.
Abstract
摘要
相似文献
1
Sarcopenia as a prognostic indicator of liver cirrhosis.肌肉减少症作为肝硬化的预后指标。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):8-10. doi: 10.1002/jcsm.12869. Epub 2021 Nov 23.
2
Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.肝硬化患者骨骼肌异常的临床意义。
Dig Liver Dis. 2019 Nov;51(11):1493-1499. doi: 10.1016/j.dld.2019.05.034. Epub 2019 Jun 17.
3
[Assessment and intervention strategies for sarcopenia in patients with liver cirrhosis].[肝硬化患者肌肉减少症的评估与干预策略]
Zhonghua Gan Zang Bing Za Zhi. 2021 Mar 20;29(3):199-203. doi: 10.3760/cma.j.cn501113-20210113-00025.
4
Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.肌肉减少症在肝硬化预后中的作用：超越终末期肝病模型（MELD）评分
World J Gastroenterol. 2015 Jul 7;21(25):7637-47. doi: 10.3748/wjg.v21.i25.7637.
5
Sarcopenia and liver transplant: The relevance of too little muscle mass.肌肉减少症与肝移植：肌肉量过少的相关性。
World J Gastroenterol. 2015 Oct 21;21(39):10982-93. doi: 10.3748/wjg.v21.i39.10982.
6
Impact of muscle wasting on survival in patients with liver cirrhosis.肌肉消耗对肝硬化患者生存的影响。
World J Gastroenterol. 2015 Jun 28;21(24):7357-61. doi: 10.3748/wjg.v21.i24.7357.
7
Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis.存在肌肉减少症及其变化率与肝硬化患者的长期死亡率独立相关。
J Korean Med Sci. 2018 Oct 31;33(50):e299. doi: 10.3346/jkms.2018.33.e299. eCollection 2018 Dec 10.
8
New anthropometric and biochemical models for estimating appendicular skeletal muscle mass in male patients with cirrhosis.用于评估肝硬化男性患者四肢骨骼肌量的新人体测量学和生物化学模型。
Nutrition. 2021 Apr;84:111083. doi: 10.1016/j.nut.2020.111083. Epub 2020 Nov 21.
9
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.肌肉减少症作为肝硬化预后预测因子的研究：中国多中心研究。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1948-1958. doi: 10.1002/jcsm.12797. Epub 2021 Sep 14.
10
Sarcopenia in cirrhosis: A practical overview.肝硬化中的肌肉减少症：实用概述。
Clin Med (Lond). 2020 Sep;20(5):489-492. doi: 10.7861/clinmed.2020-0089.
引用本文的文献
1
Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predicts Cachexia and Prognosis in Hepatocellular Carcinoma Patients.钆塞酸增强 MRI 衍生的功能性肝脏成像评分预测肝细胞癌患者恶病质和预后。
Curr Med Sci. 2024 Oct;44(5):1018-1025. doi: 10.1007/s11596-024-2930-y. Epub 2024 Sep 27.
2
Association between oxidative balance score and sarcopenia in US adults: NHANES 2011-2018.美国成年人氧化平衡评分与肌肉减少症之间的关联：2011 - 2018年美国国家健康与营养检查调查（NHANES）
Front Nutr. 2024 Apr 24;11:1342113. doi: 10.3389/fnut.2024.1342113. eCollection 2024.
3
Association between the oxidative balance score and low muscle mass in middle-aged US adults.美国中年成年人氧化平衡评分与低肌肉量之间的关联。
Front Nutr. 2024 Apr 5;11:1358231. doi: 10.3389/fnut.2024.1358231. eCollection 2024.
4
Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies.肌肉减少症的研究进展：机制、治疗靶点和干预策略。
Arch Pharm Res. 2024 Apr;47(4):301-324. doi: 10.1007/s12272-024-01493-2. Epub 2024 Apr 9.
5
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities.失代偿期肝硬化的营养不良和肌肉减少症相关门静脉高压症的发病机制、影响及治疗机会
Nutrients. 2023 Dec 21;16(1):35. doi: 10.3390/nu16010035.
6
A nomogram based on psoas muscle index predicting long-term cirrhosis incidence in non-cirrhotic patients with HBV-related acute‑on‑chronic liver failure.基于腰大肌指数的列线图预测非肝硬化的乙型肝炎相关慢加急性肝衰竭患者的长期肝硬化发生率。
Sci Rep. 2023 Dec 2;13(1):21265. doi: 10.1038/s41598-023-47463-4.
7
Liver Disease-Related Sarcopenia: A Predictor of Poor Prognosis by Accelerating Hepatic Decompensation in Advanced Chronic Liver Disease.肝病相关肌少症：晚期慢性肝病中加速肝失代偿从而导致预后不良的一个预测因素。
Cureus. 2023 Nov 19;15(11):e49078. doi: 10.7759/cureus.49078. eCollection 2023 Nov.
8
The interplay of physical and cognitive function in rehabilitation of interstitial lung disease patients: a narrative review.间质性肺疾病患者康复中身体与认知功能的相互作用：一项叙述性综述
J Thorac Dis. 2023 Aug 31;15(8):4503-4521. doi: 10.21037/jtd-23-209. Epub 2023 Jul 24.
9
Mildly Low Serum Sodium Levels in Chronic Liver Disease: At Risk for Sarcopenia and Portal Hypertension.慢性肝病患者血清钠水平轻度降低：存在肌肉减少症和门静脉高压的风险
Cureus. 2023 Aug 30;15(8):e44419. doi: 10.7759/cureus.44419. eCollection 2023 Aug.
10
Association between systemic immune-inflammation index and low muscle mass in US adults: a cross-sectional study.美国成年人全身免疫炎症指数与低肌肉量的关系：一项横断面研究。
BMC Public Health. 2023 Jul 24;23(1):1416. doi: 10.1186/s12889-023-16338-8.
本文引用的文献
1
Liver cirrhosis.肝硬化。
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
2
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.肌肉减少症作为肝硬化预后预测因子的研究：中国多中心研究。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1948-1958. doi: 10.1002/jcsm.12797. Epub 2021 Sep 14.
3
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.肝硬化患者的营养不良、衰弱和肌肉减少症：美国肝病研究协会2021年实践指南
Hepatology. 2021 Sep;74(3):1611-1644. doi: 10.1002/hep.32049.
4
Acute-on-chronic liver failure: A distinct clinical syndrome.慢加急性肝衰竭：一种独特的临床综合征。
J Hepatol. 2021 Jul;75 Suppl 1:S27-S35. doi: 10.1016/j.jhep.2020.11.047.
5
Sarcopenia and frailty in decompensated cirrhosis.失代偿期肝硬化中的肌肉减少症和衰弱。
J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1):S147-S162. doi: 10.1016/j.jhep.2021.01.025.
6
Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute-on-Chronic Liver Failure.患者虚弱与急性加重慢性肝衰竭住院风险独立相关。
Liver Transpl. 2021 Jan;27(1):16-26. doi: 10.1002/lt.25896. Epub 2020 Oct 28.
7
Acute-on-Chronic Liver Failure.慢加急性肝衰竭
N Engl J Med. 2020 May 28;382(22):2137-2145. doi: 10.1056/NEJMra1914900.
8
Skeletal muscle loss phenotype in cirrhosis: A nationwide analysis of hospitalized patients.肝硬化患者的骨骼肌丢失表型：一项全国范围内住院患者的分析。
Clin Nutr. 2020 Dec;39(12):3711-3720. doi: 10.1016/j.clnu.2020.03.032. Epub 2020 Apr 3.
9
Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease.持续的肌肉减少会增加肝硬化患者的死亡率：病因对肝脏疾病的影响。
Liver Int. 2020 May;40(5):1178-1188. doi: 10.1111/liv.14358. Epub 2020 Jan 26.
10
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.北美专家关于肝移植中肌肉减少症的观点声明。
Hepatology. 2019 Nov;70(5):1816-1829. doi: 10.1002/hep.30828. Epub 2019 Aug 19.
Zotero 插件